Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Clinical trial NCT04002947 · RECRUITING
Trial details
- NCT number
- NCT04002947
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-05
- Primary completion
- 2027-05-31
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.